Key result
Longer arrhythmia duration linked to ~14% lower odds of maintaining sinus rhythm post-cardioversion.
Why the study?
Arrhythmia recurrence after successful elective electrical cardioversion for persistent AF or AFL is common, and factors influencing short- and long-term sinus rhythm maintenance need clarification.
Cohort (n=297)
No
Odds Ratio: 0.863 (95% CI 0.76–0.98)
p-value: p=0.026
Sinus rhythm is more likely to be maintained after elective electrical cardioversion in patients who are non-smokers, have fewer comorbidities, smaller left atria, a shorter arrhythmia duration, and receive concurrent antiarrhythmic therapy.
Supports earlier cardioversion timing for short-term rhythm control in persistent AF; leaves open whether duration-based selection improves outcomes in prospective trials.
Introduction Electrical cardioversion (ECV) effectively restores sinus rhythm in patients with persistent atrial fibrillation (AF) and atrial flutter (AFL), although arrhythmia recurrence is common. We aimed to identify factors associated with a higher probability of maintaining sinus rhythm one month after successful ECV, and after one year in those who were arrhythmia-free after the first month. Methods This retrospective, single-center study included patients who underwent elective ECV for persistent AF or AFL between January 2011 and June 2023. Clinical, electrocardiographic, and echocardiographic characteristics were analyzed to identify parameters associated with the maintenance of sinus rhythm. Results We included 297 ECV procedures. ECV was successful in 91.9% of patients and sinus rhythm was maintained in 89.7% of them at one month and in 40.3% at one year follow-up. Shorter arrhythmia duration (OR = 0.863, 95% CI: 0.76–0.98, p = 0.026) and ventricular pacing on the pre-procedural ECG (OR = 5.212, 95% CI: 1.16–23.48, p = 0.032) were associated with one-month success. Factors associated with one-year sinus rhythm maintenance in patients who were in sinus rhythm during monthly follow-up were smaller left atrial dimensions (OR = 0.817, 95%CI: 0.77–0.98, p = 0.022), the first-ever arrhythmia episode (OR = 3.320, 95%CI: 1.10–10.05, p = 0.034), lower CHA 2 DS 2 -VASc score (OR = 0.132, 95%CI: 0.03–0.54, p = 0.005), non-smoking status (OR = 0.120, 95%CI: 0.04–0.37, p < 0.001), no previous ECV (OR = 0.082, 95%CI: 0.01–0.47, p = 0.005), and antiarrhythmic therapy (OR = 2.486, 95%CI: 1.01–8.65, p = 0.05). Conclusions ECV is a reasonable rhythm-control strategy in AF/AFL particularly when performed early after arrhythmia onset, in non-smokers and patients with fewer comorbidities, antiarrhythmic treatment, smaller left atrium and no prior ECV.
No takes yet. Share an insight, caveat, or question.
Radovanović et al. (2026) conducted a cohort in Persistent atrial fibrillation and atrial flutter (n=297). Shorter duration of atrial arrhythmia vs. Longer duration of atrial arrhythmia was evaluated on Maintenance of sinus rhythm at one month after successful cardioversion (OR 0.863, 95% CI 0.76-0.98, p=0.026). Shorter duration of the current atrial arrhythmia episode was independently associated with maintenance of sinus rhythm at one month after successful electrical cardioversion (OR 0.863).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: